Dr. Stephen Kingsmore – A Vision for Transforming Medicine with Rapid Genome Sequencing (Part 1)

Dr. Stephen Kingsmore, MD, DSc, is the President and CEO of the Rady Pediatric Genomics and Systems Medicine Institute. Dr. Kingsmore spoke at the... Read More
March 1, 2017

Freenome Announces $65 Million in Series A Funding, Led by Andreessen Horowitz

Freenome, the health technology company reinventing disease management through systematized early detection and intervention, announced today that it has raised $65 million USD in... Read More
March 1, 2017

Illumina Announces the iHope Network, an Expansion of Its iHope Philanthropic Clinical Whole Genome Sequencing Program

Illumina, Inc. has announced the launch of the iHope Network, a consortium of member institutions who have committed to providing clinical whole genome sequencing... Read More
March 1, 2017

Bristol-Myers Squibb Expands Focus on Precision Medicine with Investment and Planned Collaboration with GRAIL on Blood-Based Cancer Screening

Bristol-Myers Squibb Company announced today its equity investment and plans for a research collaboration with GRAIL Inc., a life sciences company whose mission is... Read More
February 23, 2017

Orion Health Begins Migration of Patient Records to Amazon Web Services

Orion Health™ has announced the company will migrate its Amadeus precision medicine platform to the Amazon Web Services, Inc. (AWS) Cloud. Orion Health’s software... Read More
February 23, 2017

Cancer Experience Survey Reveals Gap in Educating Patients on Latest Diagnostic and Treatment Advancements

More than two-thirds of cancer patients and their caregivers have limited knowledge about the latest advancements in diagnostic and treatment options to help inform... Read More
February 23, 2017

Cancer Patients Can Now Read a Molecular Analysis of Their Cancer That They Can Understand

Perthera, Inc., a full-service precision medicine company, has developed a report empowering cancer patients to make informed decisions regarding their treatment options. Perthera began... Read More
February 23, 2017

SeraCare Life Sciences Announces New Highly Multiplexed Fusion RNA Assay Reference Standards

SeraCare Life Sciences, Inc. announced the launch of Seraseq™ Fusion RNA Mix v2 and Seraseq FFPE Fusion RNA Reference Material v2. The two new... Read More
February 9, 2017

Epinomics to Collaborate with the Parker Institute for Cancer Immunotherapy at Stanford University to Bring Precision Medicine to Cancer Immunotherapies

Researchers from Epinomics will collaborate with the research team led by Crystal Mackall, MD, director of the Parker Institute for Cancer Immunotherapy at Stanford,... Read More
February 7, 2017

Janssen Human Microbiome Institute Announces Multiple Collaborations to Accelerate the Translation of Microbiome Science into Health Solutions

Janssen Research & Development, LLC (Janssen)  has announced several new collaborations through its Janssen Human Microbiome Institute (JHMI) focused on advancing the discovery, development... Read More
February 7, 2017

MD Anderson and Guardant Health Announce Partnership to Make Comprehensive Liquid Biopsy Part of Oncology Standard of Care

The University of Texas MD Anderson Cancer Center and Guardant Health have announced a multi-year partnership designed to accelerate comprehensive liquid biopsy technology into... Read More
February 7, 2017

Luminex Corporation Reports Fourth Quarter And Full Year 2016 Results

Luminex Corporation (NASDAQ:LMNX) announced financial results for the fourth quarter and full year 2016 ended December 31, 2016. Financial and operating highlights include the... Read More
February 7, 2017

Mission Bio Receives Investment from Life Science Angels

Mission Bio, Inc. announced today that it has secured funding from U.S. top ranked angel investment group Life Science Angels (LSA) in a seed... Read More
February 7, 2017

FDB and Translational Software Announce Collaboration to Deliver Pharmacogenomic Drug Knowledge

FDB (First Databank, Inc.), the leading provider of clinical drug knowledge that improves medication-related decisions and patient outcomes, and Translational Software, Inc. (TSI), a... Read More
January 26, 2017

Precision Medicine Advances Brain Tumor Diagnosis and Treatment in Children

Boston, MA – A study, led by the Harvard-affiliated Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, has demonstrated the utility of precision medicine in... Read More
January 26, 2017

Ebola Survivors Have Different Transcriptome Profiles from Those Who Die

Liverpool, UK – Transcriptomic profiles can distinguish those who more likely to survive Ebola from those who are more likely to die from the... Read More